Version classiqueVersion mobile

Non-Communicable Disease Prevention

Wanrudee Isaranuwatchai
Rachel A. Archer
Yot Teerawattananon
et al.


Texte intégral

1First, we would like to thank our funders for their generous support and for making our vision for this project a reality: the Prince Mahidol Award Foundation (PMAF), the Thai Health Promotion Foundation (THF) and the international Decision Support Initiative (iDSI).

2The editors gratefully acknowledge the contribution of all the authors of this work, for without their diligence, commitment and expertise, this book would not have been possible. We specifically thank the following: Dr. Adam Elshaug (University of Sydney, Australia), Ms. Alia Luz (Health Intervention and Technology Assessment Program (HITAP), Thailand), Ms. Arisa Shichijo (Hitotsubashi University, Japan), Dr. David Kim (Tufts Medical Center, United States), Dr. Jesse Boardman Bump (Harvard University, United States), Dr. Kalipso Chalkidou (Center for Global Development in Europe, United Kingdom), Ms. Manushi Sharma (HITAP, Thailand), Dr. Melitta Zsuzsanna Jakab (World Health Organization, Spain), Dr. Peter Neumann (Tufts Medical Center, United States), Dr. Peter Smith (Imperial College London, United Kingdom), Ms. Rachel Bacon (Tufts Medical Center, United States), Dr. Ryota Nakamura (Hitotsubashi University, Japan), Ms. Sumithra Krishnamurthy Reddiar (Harvard University, United States), Dr. Tazeem Bhatia (Public Health England, United Kingdom), Dr. Thunyarat Anothaisintawee (Faculty of Medicine, Ramathibodi Hospital, Thailand) and Ms. Waranya Rattanavipapong (HITAP, Thailand). We would also like to thank the following individuals who have supported the writing of chapters. Thanks to Dr. Olaa Mohamed-Ahmed (Public Health England, United Kingdom) for their contribution to the appendices for Chapter 4 and thanks to Assistant Professor Kanokporn Sukhato, Dr. Kridsada Chareonrungrueangchai and Dr. Keerati Wongkawinwoot (all from Ramathibodi Hospital, Thailand) for working on the study selection and data extraction of the umbrella review in Chapter 7.

3We are especially grateful to Ms. Benjarin Santatiwongchai and Ms. Jirata Tienphati and rest of the HITAP communication team for their tireless support in the communication and presentation of this work. We also deeply appreciate all the efforts of the HITAP staff who have helped in the coordination and administration of the project.

4Our external reviewers, whom we thank for their support in advancing our work, were: Dr. Amanda Glassman (Center for Global Development, United States), Dr. Shankar Prinja (PGIMER, India), Ms. Ursula Giedion (International Health Policy Consultant, Switzerland), Dr. Edwine Barasa (KEMRI-Wellcome Trust, Kenya), Dr. Arian Hatefi (University of California San Francisco, United States), Dr. Justin Parkhurst (London School of Economics, United Kingdom), Dr. Bundit Sornpaisarn (University of Toronto, Canada), Dr. Sara Bennett (Johns Hopkins Bloomberg School of Public Health, United States), Dr. Jeremy Addison Lauer (World Health Organization, Switzerland) and Ms. Priya Kanayson (NCD Alliance, United States).

5Our thanks also to those listed below for reviewing our preliminary findings and also providing invaluable feedback:

  • Dr. Anita Jain (The BMJ, India)

  • Dr. Bundit Sornpaisarn (University of Toronto, Canada)

  • Dr. Chanuantong Tanasugarn (Mahidol University, Thailand)

  • Dr. Douglas Webb (United Nations Development Program, United States)

  • Ms. Emily Kobayashi (Clinton Health Access Initiative, United States) Dr. Kanchan Mukherjee (Tata Institute of Social Sciences, India)

  • Dr. Karen Hofman (PRICELESS SA, South Africa)

  • Dr. Kelvin Tan (Ministry of Health, Singapore)

  • Ms. Milin Sakornsin (Thai Health Promotion Foundation, Thailand)

  • Dr. Myo Paing (World Health Organization, Myanmar)

  • Dr. Naomi Hamada (Ministry of Health and Medical Services, Fiji)

  • Mr. Pempa (Health Technology Assessment Program, Bhutan)

  • Ms. Saudamini Dabak (HITAP, Thailand)

  • Dr. Suchita Bhattacharyya (University of Liverpool, United Kingdom) Dr. Sumudu Karunaratna (Ministry of Health, Sri Lanka)

  • Dr. Tea Collins (World Health Organization, Switzerland)

6The authors of Chapter 2 and the project team gratefully acknowledge the contributions of their interviewees.

7Finally, we owe a sincere thanks to the contributors who submitted case studies of their experiences with Best, Wasted and Contestable Buys in their local settings, in particular to Mr. Pempa, Dr. Rohan Jayasuriya, Dr. Sumudu Karunaratne and Dr. Amala de Silva, whose case studies were chosen as special features. We also acknowledge Dr. Koum Kanal, Dr. Karen Hofman, Mr. Gavin Surgey et al., Dr. Cristóbal Cuadrado and Ms. Frances Claire Onagan, whose case studies were discussed in the book. Thanks is also given to Ms. Aparna Ananthakrishnan from HITAP for proofreading this book.


Rechercher dans OpenEdition Search

Vous allez être redirigé vers OpenEdition Search